1. Home
  2. GNPX vs EVTV Comparison

GNPX vs EVTV Comparison

Compare GNPX & EVTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • EVTV
  • Stock Information
  • Founded
  • GNPX 2009
  • EVTV 2012
  • Country
  • GNPX United States
  • EVTV United States
  • Employees
  • GNPX N/A
  • EVTV N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • EVTV Auto Manufacturing
  • Sector
  • GNPX Health Care
  • EVTV Consumer Discretionary
  • Exchange
  • GNPX Nasdaq
  • EVTV Nasdaq
  • Market Cap
  • GNPX 7.0M
  • EVTV 5.4M
  • IPO Year
  • GNPX 2018
  • EVTV 2017
  • Fundamental
  • Price
  • GNPX $0.29
  • EVTV $0.25
  • Analyst Decision
  • GNPX Strong Buy
  • EVTV
  • Analyst Count
  • GNPX 1
  • EVTV 0
  • Target Price
  • GNPX $10.00
  • EVTV N/A
  • AVG Volume (30 Days)
  • GNPX 2.6M
  • EVTV 113.1K
  • Earning Date
  • GNPX 05-16-2025
  • EVTV 05-19-2025
  • Dividend Yield
  • GNPX N/A
  • EVTV N/A
  • EPS Growth
  • GNPX N/A
  • EVTV N/A
  • EPS
  • GNPX N/A
  • EVTV N/A
  • Revenue
  • GNPX N/A
  • EVTV $1,870,060.00
  • Revenue This Year
  • GNPX N/A
  • EVTV N/A
  • Revenue Next Year
  • GNPX N/A
  • EVTV N/A
  • P/E Ratio
  • GNPX N/A
  • EVTV N/A
  • Revenue Growth
  • GNPX N/A
  • EVTV N/A
  • 52 Week Low
  • GNPX $0.22
  • EVTV $0.23
  • 52 Week High
  • GNPX $4.09
  • EVTV $2.61
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 48.94
  • EVTV 42.22
  • Support Level
  • GNPX $0.27
  • EVTV $0.24
  • Resistance Level
  • GNPX $0.36
  • EVTV $0.27
  • Average True Range (ATR)
  • GNPX 0.03
  • EVTV 0.02
  • MACD
  • GNPX 0.01
  • EVTV 0.00
  • Stochastic Oscillator
  • GNPX 47.45
  • EVTV 31.51

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

Share on Social Networks: